I suppose we will have to agree to disagree. Y
Post# of 36537
(Total Views: 307)
Posted On: 04/06/2020 10:57:15 AM
I suppose we will have to agree to disagree.
You feel there is “little downside” to delaying the NGIO IPO.
I view the NGIO IPO as one of the few levers Joe has left to pull in order to get the parts moving in GNBT. Even if the S-1 for GNBT is approved, Joe won’t have access to capital via that lever until the SP goes up to a reasonable level. So, IMHO, he will pull the NGIO lever as quickly as he can while getting and maintaining a NAZ listing for NGIO.
The downside I see is that we are frozen here in OTC-land, we limp along w various sketchy financings that put us at further risk, our assets sit idle, our patents age, we run low on funds, and, frankly, we run the risk of insolvency.
You feel there is “little downside” to delaying the NGIO IPO.
I view the NGIO IPO as one of the few levers Joe has left to pull in order to get the parts moving in GNBT. Even if the S-1 for GNBT is approved, Joe won’t have access to capital via that lever until the SP goes up to a reasonable level. So, IMHO, he will pull the NGIO lever as quickly as he can while getting and maintaining a NAZ listing for NGIO.
The downside I see is that we are frozen here in OTC-land, we limp along w various sketchy financings that put us at further risk, our assets sit idle, our patents age, we run low on funds, and, frankly, we run the risk of insolvency.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼